Pulmonary vascular and cardiac impairment in interstitial lung disease
Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of...
Main Authors: | Marios Panagiotou, Alistair C. Church, Martin K. Johnson, Andrew J. Peacock |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2017-01-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/26/143/160053.full |
Similar Items
-
Cardiac geometry, as assessed by cardiac magnetic resonance, can differentiate subtypes of chronic thromboembolic pulmonary vascular disease
by: Michael McGettrick, et al.
Published: (2022-12-01) -
Hydroxychloroquine on the Pulmonary Vascular Diseases in Interstitial Lung Disease: Immunologic Effects, and Virus Interplay
by: Jun-Jun Yeh, et al.
Published: (2022-05-01) -
Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility
by: Matthew Chin, et al.
Published: (2018-06-01) -
Impairment of skeletal muscle oxygen extraction and cardiac output are matched in precapillary pulmonary hypertension
by: Harrison Stubbs, et al.
Published: (2021-08-01) -
Value of pulmonary rehabilitation in interstitial lung diseases
by: Anwar Ahmed Elganady, et al.
Published: (2020-01-01)